Clinical Trial: Prognostic Value of CAR, AFR and Ferritin in Non-M3 AML

U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07810829) titled 'Prognostic Value of CAR, AFR and Ferritin in Non-M3 AML' on Sept. 01.

Brief Summary: This prospective cohort study aims to evaluate the prognostic significance of the C-reactive protein-to-albumin ratio (CAR), albumin-to-fibrinogen ratio (AFR), and serum ferritin level in newly diagnosed de novo non-M3 acute myeloid leukemia patients at Assiut University Hospitals.

Study Start Date: Sept. 01

Study Type: OBSERVATIONAL

Condition: Acute Myeloid Leukemia Non-M3 Acute Myeloid Leukemia De Novo Acute Myeloid Leukemia With Multilineage Dysplasia

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Assiut University

Information provided b...